U.S. Contract Research Organization (CROs) - A business model for sustainable, strategic relationships, Market Expected to reach US$ 25,049.0 Million by 2027 | Finds, Coherent Market Insights

Drivers

Increased volume of clinical trials are fuelling growth of the U.S. contract research organization (CROs) market during the forecast period.

In the type of outsourced pharmaceutical testing services, a contract research organization (CRO) is a service provider agency that provides multiple drug discovery and clinical data processing services to pharmaceutical and biotechnology companies involved in clinical trials. CROs are divided into three categories: big, medium, and small niche specialist classes.

Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3179

Increased use of regulatory outsourcing services by pharmaceutical and other companies in order to obtain different grants such as quick track classification and orphan drug designation for their drugs in order to achieve faster FDA approvals is expected to drive growth of the U.S. contract research organization (CROs) market over the forecast period. Several rare cases go untreated despite the acceptance of over 500 orphan drug treatments in the U.S. As per the Center for Drug Evaluation and Research, a division of the U.S. Food & drug Administration, 34 out of 59 new drugs for treating orphan diseases were approved in the United States in 2018.

The demand for U.S. contract research organizations (CROs) is projected to reach US$ 12,174.4 million in 2019, with a CAGR of 9.4% by 2027.

Increasing technical advances in the field of clinical science, such as the use of artificial intelligence and machine learning, are expected to fuel the growth of the U.S. contract research company (CRO) market over the forecast period.

Artificial intelligence and machine learning, along with big data, are supposed to increase clinical trial performance and speed up the medication approval process. Artificial intelligence can aid in the early detection of possible risks in the clinical discovery phase, enabling researchers to cut costs and time spent on testing. For processing and analyzing various real-time data, Artificial Intelligence may be used in conjunction with wearable devices. Patients do not need to fly for site visits during clinical trials if wearable devices are used effectively. The framework will also compare data sets from ongoing experiments with patient medical reports and make appropriate recommendations. Over the projected period, these trends are expected to accelerate market growth. BioClinica, a global life science services provider, extended and upgraded the SMART technology portfolio in June 2018, which now includes medical imaging, electronic data capture (EDC), and interactive response technology (IRT) solutions for effective clinical trial data analysis.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3179

Restraints

Price volatility and the hidden expense of clinical testing facilities, on the other hand, are likely to stymie demand growth over the projected period. Furthermore, with the increased usage of technical platforms, such as applications for clinical record collection, database, paper processing, among others, other costs are included in the sector. While the use of advanced technologies improves the overall process and offers high-quality data, it raises the cost of outsourcing services, which is projected to slow the growth of the U.S. contract research organization (CRO) market over the forecast period.

Competitive Landscape

Key players contributing in the U.S. contract research organization (CRO) market are Amarex Clinical Research LLC, WCCT Global Inc., RHO, Inc., Spaulding Clinical Research, BioClinica Inc., Absolute Research Solutions, Comparative Biosciences, Inc., Theorem Clinical Research, Linical Accelovance, Pharm-Olam, CPC Clinical Research, CMIC Holdings Co., Ltd, Envigo, Wuxi Apptec, Pharmaceutical Product Development (PPD), PSI, Grayline, Integrium, LLC, Novum, Shin Nippon Biomedical Laboratories, Ltd., MedTrials, Cmed, Clindatrix, Inc., ICON Public Limited Corporation, Medpace Holdings, Inc, Clinipace, EPS International, Axis Clinicals LLC, AlcheraBio LLC, Accumedix, Inc., Pharmaron, Axiom Real-Time Metrics, Neurovasc Preclinical Services, Inc., BioPharma Services Inc., Celerion, CATO Research LLC, and Arianne Corporation.

Table of Contents

1. Research Objectives and Assumptions
• Research Objectives
• Assumptions
• Abbreviations
2. Market Purview
• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Service Type
• Market Snippet, By Therapeutic Application
• Market Snippet, By Size of CRO
• Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
• Market Dynamics
• Drivers
• Restraints & Challenges
• Market Opportunities
• Merger and Acquisitions
• Key to a Successful CTMS Solution
4. U.S. Contract Research Organization (CROs) Market, By Service Type, 2016 - 2027 (US$ Million)
• Introduction
• Market Share Analysis, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, 2016 - 2027
• Segment Trends
• Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Preclinical studies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Early Phase I – Iia
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Phase IIa – III
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Phase IIIb – IV
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Drug Development
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Medical Coding and Writing
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Monitoring
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Clinical Data Management
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Bio-statistics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Site Management
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Protocol Development
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Biomarker Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
5. U.S. Contract Research Organization (CROs) Market, By Therapeutic Application, 2016 - 2027 (US$ Million)
• Introduction
• Market Share Analysis, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, 2016 - 2027
• Segment Trends
• Oncology
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Cardiovascular Diseases
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Central Nervous System Diseases
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Infectious Diseases
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Metabolic Disorders
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Immunological Disorders
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Respiratory Disorders
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
6. U.S. Contract Research Organization (CROs) Market, By Size of CRO, 2016 - 2027 (US$ Million)
• Introduction
• Market Share Analysis, By Region, 2019 and 2027 (%)
• Y-o-Y Growth Analysis, For Regions, 2016 – 2027
• Segment Trends
• Small Size
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Medium Size
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
• Large Size
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
7. Competitive Landscape
• Heat Map Analysis
• Market Share Analysis
• Company Profiles
• Analyst Views
8. Section
• Research Methodology
• About us and Services

Other Related Reports:

Peptide Synthesis Market To Surpass US$ 546.3 Million By 2027

Chronic Gingivostomatitis Treatment Market To Surpass US$ 20,175.2 Million By 2027

Softgel Capsule Market To Surpass US$ 8,743.52 Million By 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837